Pfizer
PFE
PFE
2,239 hedge funds and large institutions have $154B invested in Pfizer in 2017 Q4 according to their latest regulatory filings, with 282 funds opening new positions, 858 increasing their positions, 861 reducing their positions, and 59 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2,239
Holders Change
+203
Holders Change %
+9.97%
% of All Funds
50.85%
Holding in Top 10
162
Holding in Top 10 Change
-13
Holding in Top 10 Change %
-7.43%
% of All Funds
3.68%
New
282
Increased
858
Reduced
861
Closed
59
Calls
$937M
Puts
$1.28B
Net Calls
-$346M
Net Calls Change
-$564M
Top Buyers
| 1 |
BlackRock
New York
|
+$441M |
| 2 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
+$414M |
| 3 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
+$310M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$289M |
| 5 |
Bank of New York Mellon
New York
|
+$273M |
Top Sellers
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$595M |
| 2 |
Credit Agricole
Montrouge Cedex,
France
|
-$437M |
| 3 |
MC
Maverick Capital
Dallas,
Texas
|
-$261M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$244M |
| 5 |
Renaissance Technologies
New York
|
-$167M |
